Northern Trust Corp Castle Biosciences Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Castle Biosciences Inc stock. As of the latest transaction made, Northern Trust Corp holds 261,930 shares of CSTL stock, worth $7.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
261,930
Previous 238,491 9.83%
Holding current value
$7.45 Million
Previous $5.19 Million 43.9%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$17.4 - $31.47 $407,838 - $737,625
23,439 Added 9.83%
261,930 $7.47 Million
Q2 2024

Aug 14, 2024
SELL
$18.84 - $24.94 $111,099 - $147,071
-5,897 Reduced 2.41%
238,491 $5.19 Million
Q1 2024

May 14, 2024
SELL
$18.06 - $25.3 $101,045 - $141,553
-5,595 Reduced 2.24%
244,388 $5.41 Million
Q4 2023

Feb 13, 2024
BUY
$12.19 - $22.43 $74,810 - $137,652
6,137 Added 2.52%
249,983 $5.39 Million
Q3 2023

Nov 13, 2023
BUY
$13.28 - $20.3 $89,799 - $137,268
6,762 Added 2.85%
243,846 $4.12 Million
Q2 2023

Aug 11, 2023
BUY
$11.66 - $26.0 $132,714 - $295,932
11,382 Added 5.04%
237,084 $3.25 Million
Q1 2023

May 15, 2023
SELL
$19.47 - $28.49 $85,492 - $125,099
-4,391 Reduced 1.91%
225,702 $5.13 Million
Q4 2022

Feb 13, 2023
BUY
$18.08 - $30.0 $47,459 - $78,750
2,625 Added 1.15%
230,093 $5.42 Million
Q3 2022

Nov 14, 2022
BUY
$22.51 - $34.32 $120,135 - $183,165
5,337 Added 2.4%
227,468 $5.93 Million
Q2 2022

Aug 12, 2022
BUY
$16.0 - $45.99 $156,896 - $450,977
9,806 Added 4.62%
222,131 $4.88 Million
Q1 2022

May 13, 2022
SELL
$33.17 - $46.98 $210,198 - $297,712
-6,337 Reduced 2.9%
212,325 $9.53 Million
Q4 2021

Feb 08, 2022
SELL
$39.06 - $67.58 $192,682 - $333,372
-4,933 Reduced 2.21%
218,662 $9.37 Million
Q3 2021

Nov 15, 2021
BUY
$60.13 - $77.6 $47,622 - $61,459
792 Added 0.36%
223,595 $14.9 Million
Q2 2021

Aug 13, 2021
BUY
$50.07 - $76.78 $2.29 Million - $3.52 Million
45,829 Added 25.9%
222,803 $16.3 Million
Q1 2021

May 12, 2021
BUY
$58.92 - $97.33 $857,403 - $1.42 Million
14,552 Added 8.96%
176,974 $12.1 Million
Q4 2020

Feb 11, 2021
BUY
$43.6 - $73.05 $353,901 - $592,946
8,117 Added 5.26%
162,422 $10.9 Million
Q3 2020

Nov 16, 2020
BUY
$38.47 - $52.03 $949,054 - $1.28 Million
24,670 Added 19.03%
154,305 $7.94 Million
Q2 2020

Aug 14, 2020
BUY
$27.28 - $43.01 $589,057 - $928,714
21,593 Added 19.99%
129,635 $4.89 Million
Q1 2020

May 14, 2020
BUY
$23.08 - $35.53 $1.19 Million - $1.83 Million
51,558 Added 91.28%
108,042 $3.22 Million
Q4 2019

Feb 14, 2020
BUY
$15.74 - $35.04 $83,217 - $185,256
5,287 Added 10.33%
56,484 $1.94 Million
Q3 2019

Nov 13, 2019
BUY
$18.09 - $27.92 $926,153 - $1.43 Million
51,197 New
51,197 $926,000

Others Institutions Holding CSTL

# of Institutions
202
Shares Held
26M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $748M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email